Biovie Inc.

BIVI Nasdaq SEC CIK 1580149
Follow Biovie Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Net income −$5.6M −10.2% vs same quarter last year
EPS, diluted −$0.68 +30.6% vs same quarter last year
Operating cash flow −$2.9M +3.9% vs same quarter last year
Operating income −$5.6M −6.9% vs same quarter last year
Net income by quarter
−$7.1M
−$2.8M
−$3.5M
−$5.1M
−$6.1M
−$5.3M
−$5.6M
−$5.6M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
−$150M−$100M−$50M$0FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearNet income
FY26−$22.1M
FY25−$17.5M
FY24−$32.1M
FY23−$50.3M
FY22−$26.1M
FY21−$130.2M
FY20−$16.7M
FY19−$2.4M
FY18−$2.4M
FY17−$1.3M
FY16−$431.9K
FY15−$233K
FY14−$321.9K
FY13−$17.5K